相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immune effector cell-associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapy for lymphoma: predictive biomarkers and clinical outcomes
Noa G. Holtzman et al.
NEURO-ONCOLOGY (2021)
Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery
Dalia Haydar et al.
NEURO-ONCOLOGY (2021)
Neogenin is highly expressed in diffuse intrinsic pontine glioma and influences tumor invasion
Julie Sesen et al.
BRAIN RESEARCH (2021)
Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
Darel Martinez Bedoya et al.
FRONTIERS IN IMMUNOLOGY (2021)
Development of Antigen-specific Chimeric Antigen Receptor KHYG-1 Cells for Glioblastoma
Chung Hyo Kang et al.
ANTICANCER RESEARCH (2021)
SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma
Joseph H. Choe et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma
Luan Sun et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis
Nicholas A. Vitanza et al.
NATURE MEDICINE (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
CLINICAL UPDATES AND CORRELATIVE FINDINGS FROM THE FIRST PATIENT WITH DIPG TREATED WITH INTRACRANIAL CAR T CELLS
Nicholas Vitanza et al.
NEURO-ONCOLOGY (2021)
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma
Chen He et al.
NATURE COMMUNICATIONS (2021)
Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies
Daniela G. M. Tantalo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
Ibrahim Yakoub-Agha et al.
HAEMATOLOGICA (2020)
Generation of diffuse intrinsic pontine glioma mouse models by brainstem-targeted in utero electroporation
Smruti K. Patel et al.
NEURO-ONCOLOGY (2020)
Finding the Keys to the CAR: Identifying Novel Target Antigens for T Cell Redirection Immunotherapies
Rebecca C. Abbott et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
PIK3CA variants selectively initiate brain hyperactivity during gliomagenesis
Kwanha Yu et al.
NATURE (2020)
B7-H3 as a Prognostic Biomarker and Therapeutic Target in Pediatric central nervous system Tumors
Uday B. Maachani et al.
TRANSLATIONAL ONCOLOGY (2020)
Design and Characterization of an All-in-One Lentiviral Vector System Combining Constitutive Anti-GD2 CAR Expression and Inducible Cytokines
Katharina Zimmermann et al.
CANCERS (2020)
Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies
Ana Rita Pombo Antunes et al.
ELIFE (2020)
Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy
Chantel Cacciotti et al.
JOURNAL OF PATHOLOGY (2020)
Augmentation of brain tumor interstitial flow via focused ultrasound promotes brain-penetrating nanoparticle dispersion and transfection
Colleen T. Curley et al.
SCIENCE ADVANCES (2020)
Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
Johanna Theruvath et al.
NATURE MEDICINE (2020)
Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymoma
Laura K. Donovan et al.
NATURE MEDICINE (2020)
Patient-derived orthotopic xenografts of pediatric brain tumors: a St. Jude resource
Kyle S. Smith et al.
ACTA NEUROPATHOLOGICA (2020)
Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy
Bassel Nazha et al.
FRONTIERS IN ONCOLOGY (2020)
CAR T Cell Therapy for Pediatric Brain Tumors
John D. Patterson et al.
FRONTIERS IN ONCOLOGY (2020)
Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity
Yura Grabovska et al.
NATURE COMMUNICATIONS (2020)
Route of 41BB/41BBL Costimulation Determines Effector Function of B7-H3-CAR.CD28ζ T Cells
Phuong Nguyen et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
Chimeric antigen receptor T-cell therapy in glioblastoma: charging the T cells to fight
Craig A. Land et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
B7-H3, a checkpoint molecule, as a target for cancer immunotherapy
Shuo Yang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy
Nicole A. P. Lieberman et al.
NEURO-ONCOLOGY (2019)
Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells
Hongwei Du et al.
CANCER CELL (2019)
Challenges to curing primary brain tumours
Kenneth Aldape et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation (vol 10, 448, 2019)
Jun Yan et al.
NATURE COMMUNICATIONS (2019)
Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma
Hayato Okamoto et al.
SCIENTIFIC REPORTS (2019)
Immunotherapeutic Targeting of GPC3 in Pediatric Solid Embryonal Tumors
Michael V. Ortiz et al.
FRONTIERS IN ONCOLOGY (2019)
Chimeric antigen receptor T cell persistence and memory cell formation
Alexander D. McLellan et al.
IMMUNOLOGY AND CELL BIOLOGY (2019)
Long-term toxicity profile of trastuzumab emtansine (T-DM1): A multicenter real-life study.
Giuseppe Buono et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Tenascin-C expression contributes to pediatric brainstem glioma tumor phenotype and represents a novel biomarker of disease
J. Qi et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
CAR T cells for brain tumors: Lessons learned and road ahead
David Akhavan et al.
IMMUNOLOGICAL REVIEWS (2019)
B7-H3 as a Novel CAR-T Therapeutic Target for Glioblastoma
Xin Tang et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres
Dean Nehama et al.
EBIOMEDICINE (2019)
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Xiao Han et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
CXCR1-or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors
Linchun Jin et al.
NATURE COMMUNICATIONS (2019)
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma
Bryan D. Choi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Histone H3.3 K27M Accelerates Spontaneous Brainstem Glioma and Drives Restricted Changes in Bivalent Gene Expression
Jon D. Larson et al.
CANCER CELL (2019)
Autologous CD19-directed chimeric antigen receptor-T cell is an effective and safe treatment to refractory or relapsed diffuse large B-cell lymphoma
Fang Bao et al.
CANCER GENE THERAPY (2019)
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
Robbie G. Majzner et al.
CLINICAL CANCER RESEARCH (2019)
Eosinophils and other peripheral blood biomarkers in glioma grading: a preliminary study
Zhenxing Huang et al.
BMC NEUROLOGY (2019)
Advances in Anti-GD2 Immunotherapy for Treatment of High-risk Neuroblastoma
Julie Voeller et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2019)
CD276 (B7-H3) Maintains Proliferation and Regulates Differentiation in Angiogenic Function in Late Endothelial Progenitor Cells
YeonSung Son et al.
STEM CELLS (2019)
A long way to the battlefront: CAR T cell therapy against solid cancers
Zhicai Wang et al.
JOURNAL OF CANCER (2019)
Clinical chimeric antigen receptor-T cell therapy: a new and promising treatment modality for glioblastoma
Michael P. Brown et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)
Emerging functions of the EGFR in cancer
Sara Sigismund et al.
MOLECULAR ONCOLOGY (2018)
Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma
Kevin Bielamowicz et al.
NEURO-ONCOLOGY (2018)
Glycogen synthase kinase 3 inhibition lowers PD-1 expression, promotes long-term survival and memory generation in antigen-specific CAR-T cells
Sadhak Sengupta et al.
CANCER LETTERS (2018)
Driving CARs on the uneven road of antigen heterogeneity in solid tumors
Nan Chen et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Leptomeningeal Metastases
Jerome J. Graber et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)
Chimeric Antigen Receptor T Cell Therapy: Challenges to Bench-to-Bedside Efficacy
Shivani Srivastava et al.
JOURNAL OF IMMUNOLOGY (2018)
Dominant-Negative TGF-β Receptor Enhances PSMA-Targeted Human CAR T Cell Proliferation And Augments Prostate Cancer Eradication
Christopher C. Kloss et al.
MOLECULAR THERAPY (2018)
Tissue-resident memory T cells at the center of immunity to solid tumors
Derk Amsen et al.
NATURE IMMUNOLOGY (2018)
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
Christopher W. Mount et al.
NATURE MEDICINE (2018)
DIPG-41. IDENTIFICATION OF BIRC5 AS A NOVEL THERAPEUTIC TARGET FOR DIFFUSE INTRINSIC PONTINE GLIOMA
Meng Li et al.
NEURO-ONCOLOGY (2018)
IMMU-12. T-CELL THERAPIES DEMONSTRATE EFFICACY WITHOUT TOXICITY IN IMMUNOCOMPETENT MODELS OF BRAINSTEM TUMORS
Matt Schuelke et al.
NEURO-ONCOLOGY (2018)
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment
Elisa Peranzoni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma
Zhongzhen Yi et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Non-inflammatory tumor microenvironment of diffuse intrinsic pontine glioma
Grant L. Lin et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Neogenin in Amygdala for Neuronal Activity and Information Processing
Xiang-Dong Sun et al.
JOURNAL OF NEUROSCIENCE (2018)
Advantages of patient-derived orthotopic mouse models and genetic reporters for developing fluorescence-guided surgery
Thinzar M. Lwin et al.
JOURNAL OF SURGICAL ONCOLOGY (2018)
Ex vivo AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8+ T cells for adoptive immunotherapy
Charlotte M. Mousset et al.
ONCOIMMUNOLOGY (2018)
Pediatric Brain Tumor Genetics: What Radiologists Need to Know
Jehan AlRayahi et al.
RADIOGRAPHICS (2018)
Engineering CAR-T Cells for Improved Function Against Solid Tumors
Michael A. Morgan et al.
FRONTIERS IN IMMUNOLOGY (2018)
Paediatric gliomas: diagnosis, molecular biology and management
Alexandros Blionas et al.
ANNALS OF TRANSLATIONAL MEDICINE (2018)
Mouse Models of Pediatric Supratentorial High-grade Glioma Reveal How Cell-of-Origin Influences Tumor Development and Phenotype
Smitha Sreedharan et al.
CANCER RESEARCH (2017)
Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting
Clare Y. Slaney et al.
CLINICAL CANCER RESEARCH (2017)
Mutant IDH1 regulates the tumor-associated immune system in gliomas
Nduka M. Amankulor et al.
GENES & DEVELOPMENT (2017)
Tumor-associated macrophages: from basic research to clinical application
Li Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Advances in Immunotherapy for Melanoma: A Comprehensive Review
Carmen Rodriguez-Cerdeira et al.
MEDIATORS OF INFLAMMATION (2017)
EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas
Faizaan Mohammad et al.
NATURE MEDICINE (2017)
Intracerebroventricular Delivery as a Safe, Long-Term Route of Drug Administration
Jessica L. Cohen-Pfeffer et al.
PEDIATRIC NEUROLOGY (2017)
CCR8+FOXp3+ Treg cells as master drivers of immune regulation
Yiftah Barsheshet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
Donald M. O'Rourke et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells
Marco Ruella et al.
CANCER DISCOVERY (2017)
Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells
Thomas Shum et al.
CANCER DISCOVERY (2017)
Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants
Giedre Krenciute et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Tenascin-C a novel regulator of brain tumor-initiating cells (BTIC) in glioma acts through NOTCH
Juliano Andreoli Miyake et al.
TRANSLATIONAL CANCER RESEARCH (2017)
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma A Phase 1 Dose-Escalation Trial
Nabil Ahmed et al.
JAMA ONCOLOGY (2017)
Emerging and Diverse Functions of the EphA2 Noncanonical Pathway in Cancer Progression
Yue Zhou et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2017)
Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma
Zhihong Chen et al.
CANCER RESEARCH (2017)
Eradication of Tumors through Simultaneous Ablation of CD276/B7-H3-Positive Tumor Cells and Tumor Vasculature
Steven Seaman et al.
CANCER CELL (2017)
Glioma: experimental models and reality
Krissie Lenting et al.
ACTA NEUROPATHOLOGICA (2017)
Armored CAR T-cells: utilizing cytokines and pro-inflammatory ligands to enhance CAR T-cell anti-tumour efficacy
Oladapo O. Yeku et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2016)
Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL
Xiuli Wang et al.
BLOOD (2016)
Survivin: a unique target for tumor therapy
Himani Garg et al.
CANCER CELL INTERNATIONAL (2016)
A Molecular Switch Abrogates Glycoprotein 100 (gp100) T-cell Receptor (TCR) Targeting of a Human Melanoma Antigen
Valentina Bianchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia
Paulina J. Paszkiewicz et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape (Publication with Expression of Concern. See vol. 129, pg. 3464, 2019)
Meenakshi Hegde et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Patient-derived xenografts: a relevant preclinical model for drug development
Luca Pompili et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
Lenka V. Hurton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies
Robert L. Bowman et al.
CELL REPORTS (2016)
Gated chimeric antigen receptor T-cells: the next logical step in reducing toxicity?
David Marc Davies et al.
TRANSLATIONAL CANCER RESEARCH (2016)
Long-Term Outcomes Following CD19 CAR T Cell Therapy for B-ALL Are Superior in Patients Receiving a Fludarabine/Cyclophosphamide Preparative Regimen and Post-CAR Hematopoietic Stem Cell Transplantation
Daniel W. Lee et al.
BLOOD (2016)
Survivin: A molecular biomarker in cancer
Praveen Kumar Jaiswal et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2015)
Focused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study
Pin-Yuan Chen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Tenascin-C: Exploitation and collateral damage in cancer management
Caroline Spenle et al.
CELL ADHESION & MIGRATION (2015)
Clinical development of IL13Rα2-targeting CAR T cells for the treatment of glioblastoma
Christine E Brown et al.
Journal for ImmunoTherapy of Cancer (2015)
Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial.
Nabil Ahmed et al.
Journal for ImmunoTherapy of Cancer (2015)
Survivin-specific T cell receptor targets tumor but not T cells
Caroline Arber et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma
S. N. Brun et al.
ONCOGENE (2015)
Tenascin-C: Form versus function
Sean P. Giblin et al.
CELL ADHESION & MIGRATION (2015)
Molecular and cellular insights into T cell exhaustion
E. John Wherry et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Netrin-1 Promotes Medulloblastoma Cell Invasiveness and Angiogenesis, and Demonstrates Elevated Expression in Tumor Tissue and Urine of Patients with Pediatric Medulloblastoma
Tomoshige Akino et al.
CANCER RESEARCH (2014)
The role of regulatory T-cells in glioma immunology
Yinn Cher Ooi et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2014)
Immunotherapy advances for glioblastoma
David A. Reardon et al.
NEURO-ONCOLOGY (2014)
Overcoming the Blood-Brain Barrier in Chemotherapy Treatment of Pediatric Brain Tumors
Linfeng Wu et al.
PHARMACEUTICAL RESEARCH (2014)
Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation
Kosuke Funato et al.
SCIENCE (2014)
Upregulation of plasmacytoid dendritic cells in glioma
Rui Wang et al.
TUMOR BIOLOGY (2014)
Gliomas and the vascular fragility of the blood brain barrier
Luiz Gustavo Dubois et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
The inducible caspase-9 suicide gene system as a safety switch to limit on-target, off-tumor toxicities of chimeric antigen receptor T cells
Tessa Gargett et al.
FRONTIERS IN PHARMACOLOGY (2014)
Current Vaccine Trials in Glioblastoma: A Review
LindaW. Xu et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma
Chris Jones et al.
NATURE REVIEWS CANCER (2014)
Netrin-1 Promotes Glioblastoma Cell Invasiveness and Angiogenesis by Multiple Pathways Including Activation of RhoA, Cathepsin B, and cAMP-response Element-binding Protein
Akio Shimizu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Netrin-1-induced activation of Notch signaling mediates glioblastoma cell invasion
Irene Ylivinkka et al.
JOURNAL OF CELL SCIENCE (2013)
B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma
Zhiping Zhou et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Combinational Targeting Offsets Antigen Escape and Enhances Effector Functions of Adoptively Transferred T Cells in Glioblastoma
Meenakshi Hegde et al.
MOLECULAR THERAPY (2013)
T Cells Redirected to EphA2 for the Immunotherapy of Glioblastoma
Kevin K. H. Chow et al.
MOLECULAR THERAPY (2013)
Glioma IL13Rα2 Is Associated with Mesenchymal Signature Gene Expression and Poor Patient Prognosis
Christine E. Brown et al.
PLOS ONE (2013)
Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma
Lihua E. Budde et al.
PLOS ONE (2013)
Chimeric Antigen Receptor T Cells Shape Myeloid Cell Function within the Tumor Microenvironment through IFN-γ and GM-CSF
Paul Spear et al.
JOURNAL OF IMMUNOLOGY (2012)
Expression of epidermal growth factor variant III (EGFRvIII) in pediatric diffuse intrinsic pontine gliomas
Gordon Li et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Eosinophils in glioblastoma biology
Colleen S. Curran et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Increased Microglia/Macrophage Gene Expression in a Subset of Adult and Pediatric Astrocytomas
Jane R. Engler et al.
PLOS ONE (2012)
Capture, crawl, cross: the T cell code to breach the blood-brain barriers
Britta Engelhardt et al.
TRENDS IN IMMUNOLOGY (2012)
Reprogramming CD19-Specific T Cells with IL-21 Signaling Can Improve Adoptive Immunotherapy of B-Lineage Malignancies
Harjeet Singh et al.
CANCER RESEARCH (2011)
Glypican-3: A new target for cancer immunotherapy
Mitchell Ho et al.
EUROPEAN JOURNAL OF CANCER (2011)
Protein Kinase B Controls Transcriptional Programs that Direct Cytotoxic T Cell Fate but Is Dispensable for T Cell Metabolism
Andrew N. Macintyre et al.
IMMUNITY (2011)
A human memory T cell subset with stem cell-like properties
Luca Gattinoni et al.
NATURE MEDICINE (2011)
Survivin as an immunotherapeutic target for adult and pediatric malignant brain tumors
Rebecca Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Successful Treatment of Melanoma Brain Metastases with Adoptive Cell Therapy
Jenny J. Hong et al.
CLINICAL CANCER RESEARCH (2010)
Differentiation and Persistence of Memory CD8+ T Cells Depend on T Cell Factor 1
Xinyuan Zhou et al.
IMMUNITY (2010)
The role of HER2 in cancer therapy and targeted drug delivery
Wanyi Tai et al.
JOURNAL OF CONTROLLED RELEASE (2010)
EGFRvIII Deletion Mutations in Pediatric High-Grade Glioma and Response to Targeted Therapy in Pediatric Glioma Cell Lines
Dorine A. Bax et al.
CLINICAL CANCER RESEARCH (2009)
Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells
Luca Gattinoni et al.
NATURE MEDICINE (2009)
The epidermal growth factor receptor family: Biology driving targeted therapeutics
M. J. Wieduwilt et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas
Hideho Okada et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Tumor antigen precursor protein profiles of adult and pediatric brain tumors identify potential targets for immunotherapy
Jian Gang Zhang et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Melanosomes-dark organelles enlighten endosomal membrane transport
Graca Raposo et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Regression of experimental medulloblastoma following transfer of HER2-specific T cells
Nabil Ahmed et al.
CANCER RESEARCH (2007)
Cardiac toxicity of trastuzumab-related regimens in HER2-overexpressing breast cancer
Michael S. Ewer et al.
CLINICAL BREAST CANCER (2007)
Expression of nine tumour antigens in a series of human glioblastoma multiforme: interest of EGFRvIII, IL-13R alpha 2, gp100 and TRP-2 for immunotherapy
Stephan Saikali et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma
D Xie et al.
BRITISH JOURNAL OF CANCER (2006)
EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics
RC Ireton et al.
CURRENT CANCER DRUG TARGETS (2005)
Characterization of CD20-transduced T lymphocytes as an alternative suicide gene therapy approach for the treatment of graft-versus-host disease
M Serafini et al.
HUMAN GENE THERAPY (2004)
Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma
A Leins et al.
CANCER (2003)
Evidence of high incidence of EGFRvIII expression and coexpression with EGFR in human invasive breast cancer by laser capture microdissection and immunohistochemical analysis
H Ge et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo
AH Mesiwala et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2002)
分享论文
